Gene transfer to cervical cancer with fiber‐modified adenoviruses
Open Access
- 20 May 2004
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 111 (5) , 698-704
- https://doi.org/10.1002/ijc.20295
Abstract
Successful adenoviral (Ad) vector–mediated strategies for cancer gene therapy mandate gene-delivery systems that are capable of achieving efficient gene delivery in vivo. In many cancer types, in vivo gene-transfer efficiency remains limited due to the low or highly variable expression of the primary Ad receptor, the coxsackie Ad receptor (CAR). In this study, we evaluated the expression of CAR on cervical cancer cells as well as CAR-independent targeting strategies to integrins (Ad5.RGD), heparan sulfate proteoglycans (Ad5.pK7) or both (Ad5.RGD.pK7). We used a panel of established cervical cancer cell lines and primary cervical cancer cells isolated from patients to quantify the expression of CAR mRNA and to evaluate the gene-transfer efficiency of fiber-modified Ads. Of the fiber-modified vectors, Ad5.pK7 and Ad5.RGD.pK7 displayed significantly enhanced gene-transfer efficiency in vitro. Gene-delivery efficiency in vivo was evaluated using an s.c. cervical cancer mouse model. Ad5.RGD.pK7 significantly improves tumor targeting in vivo, resulting in a significantly improved tumor/liver ratio in mice. Our results suggest that the double-modified Ad5.RGD.pk7 vector enhances gene transfer to clinically relevant cervical cancer substrates, while the infectivity of nontarget cells in the mouse is not increased and comparable to Ad5. The fiber-modified virus described here can help achieve higher clinical efficacy of cervical cancer gene therapy.Keywords
This publication has 30 references indexed in Scilit:
- DOUBLE GENETIC MODIFICATION OF ADENOVIRUS FIBER WITH RGD POLYLYSINE MOTIFS SIGNIFICANTLY ENHANCES GENE TRANSFER TO ISOLATED HUMAN PANCREATIC ISLETS1Transplantation, 2003
- CAR is a cell–cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFα, and TGFβGene Therapy, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancerCancer Gene Therapy, 2002
- Serum and Ascites Neutralizing Antibodies in Ovarian Cancer Patients Treated with Intraperitoneal Adenoviral Gene TherapyHuman Gene Therapy, 2002
- Ectopic Expression of the Coxsackievirus and Adenovirus Receptor Increases Susceptibility to Adenoviral Infection in the Human Cervical Cancer Cell Line, SiHaBiochemical and Biophysical Research Communications, 2001
- An Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene ExpressionMolecular Therapy, 2001
- Characterization of the Cyclooxygenase-2 Promoter in an Adenoviral Vector and Its Application for the Mitigation of Toxicity in Suicide Gene Therapy of Gastrointestinal CancersMolecular Therapy, 2001
- Using a Tropism-Modified Adenoviral Vector to Circumvent Inhibitory Factors in Ascites FluidHuman Gene Therapy, 2000
- Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell typesNature Biotechnology, 1996